Volunteers Needed- COVID 19 Hyperimmune Globlin Study- ICM Mount Sinai

New York City NY

Description

Volunteers Needed: COVID-19 Hyperimmune Globulin Study Today, we acknowledge the enormity and complexity of what we’ve been through this year and reflect on how far we’ve come in advancing care for COVID-19. We still have work to do and appreciate your help in identifying volunteers who may be right for the COVID-19 study below. COVID-19 Hyperimmune Globulin Study Emergent BioSolutions and the Icahn School of Medicine at Mount Sinai are conducting a Phase 1, double-blinded, placebo-controlled study to evaluate the safety and the pharmacokinetics of COVID-19 Hyperimmune Immunoglobulin in healthy adults who have never been infected with COVID-19. What is COVID-19 Hyperimmune Immunoglobulin? COVID-19 Hyperimmune Immunoglobulin contains purified antibodies against SAR-CoV-2, the virus that causes COVID-19. It is made from the convalescent plasma of individuals recently infected with COVID-19. COVID-19 Hyperimmune Immunoglobulin has the potential to protect and to treat against COVID-19. This study is the first step in evaluating the effectiveness of this therapy. Who is eligible? The COVID Clinical Trials Unit is looking for healthy individuals (ages 18-60) who have never tested positive for COVID-19 nor have received any COVID-19 vaccines. One overnight stay is required. Compensation for time and travel will be provided. Please direct volunteers to call 212-824-7714 or email [email protected] to see if they qualify. Best, The COVID Trials Unit at Mount Sinai